In all SURPASS programs, tirzepatide demonstrated a much greater HbA1c-lowering impact than placebo or active comparators, such as basal insulin and GLP1RAs [83, 86]
Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic
Orders are processed and shipped within 12 business days after payment clears
Tracking sleep data alongside your weight loss trajectory and dose changes creates a record that gives your sleep specialist the context they need to make informed decisions about adjusting your therapy
Start with a consultation and labs with a licensed provider, get a prescription matched to your goals, have it filled by a licensed pharmacy, and stay monitored over time
